Literature DB >> 16841086

Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-kinase enhancer-activating Akt, preventing its apoptotic cleavage and promoting cell survival.

X Tang1, Y Feng, K Ye.   

Abstract

Phosphatidylinositol 3-kinase enhancer-activating Akt (PIKE-A) binds Akt and upregulates its kinase activity, preventing apoptosis. PIKE-A can be potently phosphorylated on tyrosine residues 682 and 774, leading to its resistance to caspase cleavage. However, the upstream tyrosine kinases responsible for PIKE-A phosphorylation and subsequent physiological significance remain unknown. Here, we show that PIKE-A can be cleaved by the active apoptosome at both D474 and D592 residues. Employing fyn-deficient mouse embryonic fibroblast cells and tissues, we demonstrate that fyn is essential for phosphorylating PIKE-A and protects it from apoptotic cleavage. Active but not kinase-dead fyn interacts with PIKE-A and phosphorylates it on both Y682 and Y774 residues. Tyrosine phosphorylation in PIKE-A is required for its association with active fyn but not for Akt. Mutation of D into A in PIKE-A protects it from caspase cleavage and promotes cell survival. Thus, this finding provides a molecular mechanism accounting for the antiapoptotic action of src-family tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16841086     DOI: 10.1038/sj.cdd.4402011

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  28 in total

1.  What we have learnt about PIKE from the knockout mice.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  Int J Biochem Mol Biol       Date:  2011-06-07

2.  Fyn promotes Th17 differentiation by regulating the kinetics of RORγt and Foxp3 expression.

Authors:  Aki Ueda; Liang Zhou; Paul L Stein
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

3.  Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity.

Authors:  S Zhang; Q Qi; C B Chan; W Zhou; J Chen; H R Luo; C Appin; D J Brat; K Ye
Journal:  Cell Death Differ       Date:  2015-05-22       Impact factor: 15.828

4.  Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction.

Authors:  Margaret Chui Ling Tse; Xia Liu; Seran Yang; Keqiang Ye; Chi Bun Chan
Journal:  Mol Cell Biol       Date:  2013-02-25       Impact factor: 4.272

5.  The association of phosphoinositide 3-kinase enhancer A with hepatic insulin receptor enhances its kinase activity.

Authors:  Chi Bun Chan; Xia Liu; Kunyan He; Qi Qi; Dae Y Jung; Jason K Kim; Keqiang Ye
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

6.  Src regulates angiogenic factors and vascular permeability after focal cerebral ischemia-reperfusion.

Authors:  L Zan; X Zhang; Y Xi; H Wu; Y Song; G Teng; H Li; J Qi; J Wang
Journal:  Neuroscience       Date:  2014-01-08       Impact factor: 3.590

7.  PIKE is essential for oligodendroglia development and CNS myelination.

Authors:  Chi Bun Chan; Xia Liu; Lixia Zhao; Guanglu Liu; Chi Wai Lee; Yue Feng; Keiqang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

Review 8.  Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.

Authors:  Nicholas M Chesarino; Temet M McMichael; Jacob S Yount
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

9.  Tyrosine kinase FYN negatively regulates NOX4 in cardiac remodeling.

Authors:  Shouji Matsushima; Junya Kuroda; Peiyong Zhai; Tong Liu; Shohei Ikeda; Narayani Nagarajan; Shin-Ichi Oka; Takashi Yokota; Shintaro Kinugawa; Chiao-Po Hsu; Hong Li; Hiroyuki Tsutsui; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

10.  Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance.

Authors:  Chi Bun Chan; Xia Liu; Dae Young Jung; John Y Jun; Hongbo R Luo; Jason K Kim; Keqiang Ye
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.